Cargando…
Pharmacological management of metabolic syndrome and its lipid complications
Obesity epidemic has been spread all over the world in the past few decades and has caused a major public health concern due to its increasing global prevalence. Obese individuals are at higher risks of developing dyslipidemic characteristics resulting in increased triglyceride and LDL-cholesterol c...
Autores principales: | Binesh Marvasti, T., Adeli, Kh. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304358/ https://www.ncbi.nlm.nih.gov/pubmed/22615610 |
Ejemplares similares
-
The Role of the Gut Microbiota in Lipid and Lipoprotein Metabolism
por: Yu, Yijing, et al.
Publicado: (2019) -
Current and future pharmacological therapies for managing cirrhosis and its complications
por: Kockerling, David, et al.
Publicado: (2019) -
Complex role of autophagy in regulation of hepatic lipid and lipoprotein metabolism
por: Zamani, Mostafa, et al.
Publicado: (2017) -
Role of Gut Microbiota in Neuroendocrine Regulation of Carbohydrate and Lipid Metabolism via the Microbiota-Gut-Brain-Liver Axis
por: Wang, Shu-Zhi, et al.
Publicado: (2020) -
Pharmacological Management of Cardiorenal Syndromes
por: House, Andrew A., et al.
Publicado: (2011)